Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 155

    1.

    The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey.

    Metascreen Writing Committee, Bonadonna RC, Cucinotta D, Fedele D, Riccardi G, Tiengo A.

    Diabetes Care. 2006 Dec;29(12):2701-7.PMID: 17130208 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The impact of central obesity as a prerequisite for the diagnosis of metabolic syndrome.

    Khoo CM, Liew CF, Chew SK, Tai ES.

    Obesity (Silver Spring). 2007 Jan;15(1):262-9.PMID: 17228055 [PubMed - indexed for MEDLINE]Related articles

    3.

    The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.

    Tong PC, Kong AP, So WY, Yang X, Ho CS, Ma RC, Ozaki R, Chow CC, Lam CW, Chan JC, Cockram CS.

    Diabetes Care. 2007 May;30(5):1206-11. Epub 2007 Jan 26.PMID: 17259472 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Prevalence of vascular disease in metabolic syndrome using three proposed definitions.

    Athyros VG, Ganotakis ES, Elisaf MS, Liberopoulos EN, Goudevenos IA, Karagiannis A; GREECE-METS Collaborative Group.

    Int J Cardiol. 2007 Apr 25;117(2):204-10. Epub 2006 Jul 18.PMID: 16854482 [PubMed - indexed for MEDLINE]Related articles

    6.

    Should central obesity be an optional or essential component of the metabolic syndrome? Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study.

    Lee J, Ma S, Heng D, Tan CE, Chew SK, Hughes K, Tai ES.

    Diabetes Care. 2007 Feb;30(2):343-7.PMID: 17259505 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Comparison of the prevalence of the metabolic syndrome by WHO, AHA/NHLBI, and IDF definitions in a German population with type 2 diabetes: the Diabetes in Germany (DIG) Study.

    Koehler C, Ott P, Benke I, Hanefeld M; DIG Study Group.

    Horm Metab Res. 2007 Sep;39(9):632-5.PMID: 17846969 [PubMed - indexed for MEDLINE]Related articles

    8.

    First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran.

    Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R.

    Diabetes Care. 2009 Jun;32(6):1092-7. Epub 2009 Mar 11.PMID: 19279302 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.
    10.

    Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.

    Abdul-Ghani M, Nawaf G, Nawaf F, Itzhak B, Minuchin O, Vardi P.

    Isr Med Assoc J. 2006 Jun;8(6):378-82.PMID: 16833164 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Comparative performance of three metabolic syndrome definitions in the prediction of acute coronary syndrome.

    Koutsovasilis A, Protopsaltis J, Triposkiadis F, Kokkoris S, Milionis HJ, Zairis MN, Skoularigis J, Koukoulis G, Korantzopoulos P, Melidonis A, Foussas SG.

    Intern Med. 2009;48(4):179-87. Epub 2009 Feb 16.PMID: 19218766 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Age-Associated Increase in Abdominal Obesity and Insulin Resistance, and Usefulness of AHA/NHLBI Definition of Metabolic Syndrome for Predicting Cardiovascular Disease in Japanese Elderly with Type 2 Diabetes Mellitus.

    Sakurai T, Iimuro S, Araki A, Umegaki H, Ohashi Y, Yokono K, Ito H.

    Gerontology. 2009 Oct 10. [Epub ahead of print]PMID: 19828932 [PubMed - as supplied by publisher]Related articles

    14.

    Glycemic control in diabetes with metabolic syndrome in community hospital.

    Worawongprapa O.

    J Med Assoc Thai. 2008 May;91(5):641-7.PMID: 18672625 [PubMed - indexed for MEDLINE]Related articles

    15.

    Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.

    Cull CA, Jensen CC, Retnakaran R, Holman RR.

    Circulation. 2007 Nov 6;116(19):2119-26. Epub 2007 Oct 22.PMID: 17967769 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Impact of metabolic syndrome definitions on prevalence estimates: a study in a Portuguese community.

    Santos AC, Barros H.

    Diab Vasc Dis Res. 2007 Dec;4(4):320-7.PMID: 18158702 [PubMed - indexed for MEDLINE]Related articles

    17.

    BMI versus the metabolic syndrome in relation to cardiovascular risk in elderly Chinese individuals.

    He Y, Jiang B, Wang J, Feng K, Chang Q, Zhu S, Fan L, Li X, Hu FB.

    Diabetes Care. 2007 Aug;30(8):2128-34. Epub 2007 Apr 27.PMID: 17468350 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.

    Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB Sr, Wilson PW.

    Diabetes Care. 2007 May;30(5):1219-25. Epub 2007 Jan 26.PMID: 17259468 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes.

    Tong PC, Lee KF, So WY, Ng MH, Chan WB, Lo MK, Chan NN, Chan JC.

    Diabetes Care. 2004 Jan;27(1):216-22.PMID: 14693992 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    [Metabolic syndrome in young adults type 1 diabetic patients]

    Szadkowska A, Pietrzak I, Bodalska-Lipińska J, Czerniawska E, Wlodarczyk M, Swatko-Mikolajczyk A, Bodalski J.

    Przegl Lek. 2008;65(3):126-30. Polish. PMID: 18624120 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data